Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory acute myelogenous leukemia

M Raponi; JL Harousseau; JE Lancet; Bob Löwenberg; R Stone; Y (Yong) Zhang; W Rackoff; YX Wang; D Atkins

doi:10.1158/1078-0432.CCR-06-2609

Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory acute myelogenous leukemia

M Raponi, JL Harousseau, JE Lancet, Bob Löwenberg, R Stone, Y (Yong) Zhang, W Rackoff, YX Wang, D Atkins

Research output: Contribution to journal › Article › Academic › peer-review

58 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2254-2260
Number of pages	7
Journal	Clinical Cancer Research
Volume	13
Issue number	7
DOIs	https://doi.org/10.1158/1078-0432.CCR-06-2609
Publication status	Published - 2007

Research programs

EMC MM-02-41-03

Access to Document

10.1158/1078-0432.CCR-06-2609

http://hdl.handle.net/1765/36684

Cite this

@article{51af07890edb4613a85ad1d07c097110,

title = "Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory acute myelogenous leukemia",

author = "M Raponi and JL Harousseau and JE Lancet and Bob L{\"o}wenberg and R Stone and Zhang, {Y (Yong)} and W Rackoff and YX Wang and D Atkins",

year = "2007",

doi = "10.1158/1078-0432.CCR-06-2609",

language = "Undefined/Unknown",

volume = "13",

pages = "2254--2260",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "7",

}

TY - JOUR

T1 - Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory acute myelogenous leukemia

AU - Raponi, M

AU - Harousseau, JL

AU - Lancet, JE

AU - Löwenberg, Bob

AU - Stone, R

AU - Zhang, Y (Yong)

AU - Rackoff, W

AU - Wang, YX

AU - Atkins, D

PY - 2007

Y1 - 2007

U2 - 10.1158/1078-0432.CCR-06-2609

DO - 10.1158/1078-0432.CCR-06-2609

M3 - Article

C2 - 17404110

SN - 1078-0432

VL - 13

SP - 2254

EP - 2260

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 7

ER -